Clinical Trial Update: Pharmacodynamics and Pharmacokinetics of Insulin Detemir in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacodynamics and pharmacokinetics of insulin detemir in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED